Dimensional Fund Advisors’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$839K Buy
291,268
+158,190
+119% +$623K ﹤0.01% 2873
2025
Q4
$542K Sell
133,078
-645,048
-83% -$2.89M ﹤0.01% 2961
2025
Q3
$2.76M Sell
778,126
-216,679
-22% -$783K ﹤0.01% 2684
2025
Q2
$2.72M Sell
994,805
-399,507
-29% -$824K ﹤0.01% 2684
2025
Q1
$2.34M Sell
1,394,312
-163,184
-10% -$456K ﹤0.01% 2690
2024
Q4
$2.54M Buy
1,557,496
+478,596
+44% +$1.43M ﹤0.01% 2731
2024
Q3
$4.49M Buy
1,078,900
+556,155
+106% +$2.92M ﹤0.01% 2544
2024
Q2
$2.85M Sell
522,745
-2,262
-0.4% -$18K ﹤0.01% 2668
2024
Q1
$5.25M Buy
525,007
+468,720
+833% +$3.51M ﹤0.01% 2536
2023
Q4
$231K Sell
56,287
-15,309
-21% -$56.4K ﹤0.01% 3173
2023
Q3
$278K Buy
71,596
+44
+0.1% +$236 ﹤0.01% 3153
2023
Q2
$426K Hold
71,552
﹤0.01% 3097
2023
Q1
$233K Sell
71,552
-10,970
-13% -$43.8K ﹤0.01% 3173
2022
Q4
$324 Buy
82,522
+1,565
+2% +$7.65K ﹤0.01% 3120
2022
Q3
$483K Buy
80,957
+44,970
+125% +$325K ﹤0.01% 3051
2022
Q2
$231K Buy
+35,987
New +$229K ﹤0.01% 3232

Other funds holding SANA

Dimensional Fund Advisors's SANA Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Sana Biotechnology (SANA) stake by 119% in Q1 2026, buying an estimated $623K and bringing the position to 291,268 shares worth $839K. The position accounts for ﹤0.01% of the portfolio, ranked #2873.

Dimensional Fund Advisors first reported a position in SANA in Q2 2022 and has held it in 16 quarters since. The position peaked at $5.25M in Q1 2024. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Dimensional Fund Advisors held 291,268 shares of Sana Biotechnology worth $839K as of Q1 2026.
  • Dimensional Fund Advisors bought 158,190 Sana Biotechnology shares in Q1 2026, an estimated $623K.
  • Sana Biotechnology made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2873 holding.
  • Dimensional Fund Advisors first reported a position in Sana Biotechnology in Q2 2022 and has held it in 16 quarters since.
  • Dimensional Fund Advisors's Sana Biotechnology position peaked at $5.25M in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.